Bank Hapoalim BM lowered its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 34.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 13,773 shares of the technology company’s stock after selling 7,130 shares during the period. Bank Hapoalim BM’s holdings in Veeva Systems were worth $4,103,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Trust Co. of Toledo NA OH bought a new stake in Veeva Systems during the 2nd quarter valued at $29,000. OLD Second National Bank of Aurora purchased a new stake in Veeva Systems in the 3rd quarter worth approximately $30,000. Legacy Investment Solutions LLC acquired a new stake in shares of Veeva Systems during the 2nd quarter valued at $32,000. Maseco LLP bought a new stake in Veeva Systems during the second quarter worth approximately $35,000. Finally, Cary Street Partners Investment Advisory LLC boosted its holdings in shares of Veeva Systems by 58.3% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock worth $38,000 after buying an additional 49 shares during the period. Institutional investors own 88.20% of the company’s stock.
Insider Transactions at Veeva Systems
In other news, insider Thomas D. Schwenger sold 1,000 shares of Veeva Systems stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the transaction, the insider owned 23,204 shares in the company, valued at approximately $5,370,101.72. The trade was a 4.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 10.30% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
View Our Latest Stock Analysis on Veeva Systems
Veeva Systems Stock Performance
Shares of NYSE:VEEV opened at $222.25 on Friday. Veeva Systems Inc. has a 52-week low of $201.54 and a 52-week high of $310.50. The company has a 50-day simple moving average of $240.03 and a 200 day simple moving average of $268.98. The company has a market capitalization of $36.53 billion, a P/E ratio of 43.24, a price-to-earnings-growth ratio of 1.64 and a beta of 1.07.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.95 by $0.09. The firm had revenue of $0.81 million during the quarter, compared to analysts’ expectations of $792.37 million. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The company’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.75 EPS. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. As a group, equities analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current year.
Veeva Systems announced that its board has initiated a stock buyback program on Monday, January 5th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the technology company to buy up to 5.5% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Recommended Stories
- Five stocks we like better than Veeva Systems
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
